ProBiotix Health appoints Mads Brandt as new Global Supply Chain Director

ProBiotix Health Plc has appointed Mads Brandt as its new Global Supply Chain Director to support the company’s new strategic vision to market its patented probiotic strain LP_LDL^® through finished product formulations.

With 20 years of experience working in supply chain operations, Brandt has played a key role in various leadership positions across the life sciences and global pharma sector, including Maersk Medical, Dako, Leo Pharma A/S and ISS A/S.

His expertise in operations, supply chain and risk management, coupled with his breadth of knowledge in contract manufacturing and large-scale project management as a consultant, means Brandt will enable ProBiotix to scale up and significantly optimise their supply chain for efficiency and growth.

Steen Andersen, CEO of ProBiotix, commented: “On behalf of the team at ProBiotix, I would like to welcome Mads as our new Global Supply Chain Director and I know he will be a great asset to the Company. He brings an extensive skillset in the supply chain field, which can help greatly in supporting operational, tactical and strategical aspects of operations at a global scale.

“With his considerable experience, he can help us to build and optimise our supply chain, improve on and capitalise on our partnerships with existing and potentially new CMO’s, creating an agile and stable supply chain to create a platform for growth and help us to plan our future with efficiency. He will allow us to be even more innovative in our approach to product solutions to cater for our customer and market needs.”

Brandt moves to ProBiotix from ISS A/S – an international facilities management company based in Copenhagen, Denmark. His previous role as Operational Solutions and Transition Director meant he was accountable for end-to-end bids to operations, including designing a facilities management transition programme.

For more information on ProBiotix Health or LP_LDL^®, contact us here.